FDA

Abstract Orally disintegrating tablets (ODTs) are a solid oral dosage form designed to rapidly disintegrate in the mouth without the...

Abstract Parenteral therapies are vital in critical care, oncology, and nutrition, offering rapid onset, precise dosing, and high bioavailability. However,...

Abstract Excipients, historically regarded as inert, are now being recognised for their ability to actively modulate biological targets, including intestinal...

Abstract Excipients are essential components within drug products that contribute significantly to their overall quality, effectiveness, and safety. There is...

Abstract The enactment of Regulation No 1901/2006 on medicinal products for pediatric patients, Pediatric Research Equity and Best Pharmaceuticals for...

PRESS RELEASE Jakarta, 14 October 2025 — Chairperson of the Indonesian Food and Drug Authority (BPOM), Prof. Dr. Taruna Ikrar,...

WHY MANAGING VARIABILITY MATTERS? Pharmaceutical ingredients play a key role in drug formulation. Variations in their composition and physicochemical properties...

Abstract Enteric coating ensures a targeted release of active pharmaceutical ingredients (APIs) by protecting them from premature dissolution in the...

Abstract Posaconazole (PCZ) is a broad spectrum anti-fungal drug approved by FDA and currently used off-label for the treatment of...

Abstract Similar to other routes of administration, pulmonary formulations typically contain excipients. The panel of substances that can be used...